Lotus Pharmaceutical CoTPE:1795 +0.52%76 Interest Coverage is 3.02 as of Dec. 2025, which is 47% below its 10-year median of 5.71. GuruFocus rates TPE:1795 with a GF Score™ of 76/100 and a GF Value™ of NT$441.58 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 684 Drug Manufacturers companies, Lotus Pharmaceutical Co ranks worse than 63.89% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Lotus Pharmaceutical Co's
Operating Income
for the
three
months ended in Dec. 2025 was NT$1,494 Mil. Lotus Pharmaceutical Co's Interest Expense for the
three
months ended in Dec. 2025 was NT$-494 Mil.
Lotus Pharmaceutical Co's interest coverage for the quarter that ended in Dec. 2025 was 3.02.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Lotus Pharmaceutical Co's Interest Coverage or its related term are showing as below:
TPE:1795'
s Interest Coverage Range Over the Past 10 Years
Min: 0.88 Med: 5.71 Max: 10.74
Current: 6.59
TPE:1795's Interest Coverage is ranked worse than 63.89% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs TPE:1795: 6.59
Lotus Pharmaceutical Co (TPE:1795) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Lotus Pharmaceutical Co Interest Coverage Related Terms
Lotus Pharmaceutical Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Lotus Pharmaceutical Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
TPE:1795 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lotus Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Lotus Pharmaceutical Co's Interest Coverage falls into.
Lotus Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Pharmaceutical Co (TPE:1795) has a Interest Coverage of 3.02 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Lotus Pharmaceutical Co and its competitors. This is 47% below median its historical median of 5.71. Over the past decade, Lotus Pharmaceutical Co's Interest Coverage has ranged from 0.88 to 10.74. According to the industry distribution chart, Lotus Pharmaceutical Co ranks #437 out of 684 companies in the Drug Manufacturers industry, placing it in the top 63.9%.
Is Lotus Pharmaceutical Co's Interest Coverage too high?
Lotus Pharmaceutical Co's current Interest Coverage of 3.02 is 47% below median its 10-year median of 5.71. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 10.74. The Drug Manufacturers industry median Interest Coverage is 12.77. Lotus Pharmaceutical Co's value of 3.02 is 76.3% below this industry median. Based on the distribution chart, Lotus Pharmaceutical Co ranks #437 out of 684 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Lotus Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lotus Pharmaceutical Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Lotus Pharmaceutical Co ranks #437 out of 684 companies for Interest Coverage. This places Lotus Pharmaceutical Co in the lower half of its industry. The industry median Interest Coverage is 12.77. Lotus Pharmaceutical Co's value of 3.02 is 76.3% below this benchmark. Historically, Lotus Pharmaceutical Co's own Interest Coverage has ranged from 0.88 to 10.74 over the past decade. While the company's 10-year median is 5.71 vs. the industry median of 12.77, Lotus Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lotus Pharmaceutical Co's current Interest Coverage of 3.02 is 76.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Lotus Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Pharmaceutical Co's current Interest Coverage is 3.02, which is 47% below median its own 10-year median of 5.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Lotus Pharmaceutical Co (TPE:1795) is currently considered Possible Value Trap. The stock's GF Value™ is NT$441.58, compared to a current price of NT$191.50 — trading 56.6% below its estimated fair value. The current Interest Coverage is 3.02, which is 47% below median its 10-year median of 5.71 and 76.3% below the Drug Manufacturers industry median of 12.77. Lotus Pharmaceutical Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Lotus Pharmaceutical Co (TPE:1795), the current Interest Coverage is 3.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lotus Pharmaceutical Co (TPE:1795) Overvalued in 2026?
Based on GuruFocus' analysis, Lotus Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$191.50 is trading 56.6% below its estimated GF Value™ of NT$441.58.
GuruFocus considers Lotus Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for TPE:1795:
Interest Coverage: 3.02 (47% below median its 10-year median of 5.71)
GF Value™: NT$441.58 vs. price of NT$191.50 (56.6% below fair value)
Industry Position: 76.3% below the Drug Manufacturers median (#437 of 684)
No single metric tells the full story. See the TPE:1795 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. Along with its subsidiaries, it is engaged in the research and development, manufacturing, and sales of generic and branded pharmaceutical products, as well as consulting services. Its product portfolio comprises biosimilars, generic medicines, branded medicines, and various therapies in its research and development pipeline. The Group offers a differentiated portfolio of pharmaceuticals spanning several therapeutic areas, including oncology and immunology, CNS, women's health, primary care and lifestyle, and nephrology, among others. Geographically, it generates maximum revenue from the United States, and the rest from Taiwan, South Korea, Singapore, and other countries.
76GF Score
Get the complete analysis for TPE:1795
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1795 has been successfully added to your 
